ViiV Healthcare

Glaxo’s, Pfizer’s ViiV Licenses HIV Drug for Kids to Patent Pool

Glaxo’s, Pfizer’s ViiV Licenses HIV Drug for Kids to Patent Pool

Bloomberg

GSK wins priority status for new HIV drug in U.S.

GSK wins priority status for new HIV drug in U.S.

Reuters

Glaxo Says No Plan for Viiv Spinoff ‘at the Moment’

Glaxo Says No Plan for Viiv Spinoff ‘at the Moment’

Bloomberg

Shionogi applies for HIV drug approval in U.S., Europe

Shionogi applies for HIV drug approval in U.S., Europe

Reuters

Can These 3 Companies Take Down Gilead?

Can These 3 Companies Take Down Gilead?

Motley Fool

Glaxo Is ‘Happy’ With Human Genome Relationship, Viiv Venture

Glaxo Is ‘Happy’ With Human Genome Relationship, Viiv Venture

Bloomberg

Glaxo-Pfizer AIDS Pill May Dislodge Bristol’s, Study Suggests

Glaxo-Pfizer AIDS Pill May Dislodge Bristol’s, Study Suggests

Bloomberg

Report: GSK has no plans to sell HIV unit

Report: GSK has no plans to sell HIV unit

Fierce Biotech

News

Some Drugmakers Hold Talks With The Patent Pool

Pharmalot

News

Idenix Falls as FDA Places Hold on HIV Drug, Releases Another

Bloomberg